Clinical Trial

Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer

Name: Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer — clinical trial record (NCT07551050)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

A real-world, multicenter, prospective study to evaluate the patient-reported outcome in Chinese patients who received sacituzumab govitecan or chemotherapy of the physician's choice for metastatic breast cancer progressing on first-line treatment

Trial Details

NCT Number	NCT07551050
Lead Sponsor	Fudan University
Conditions	TNBC - Triple-Negative Breast Cancer
Enrollment	300 participants
Start Date	2026-05-15
Primary Completion	2029-04-15 (estimated)
Study Completion	2029-06-15 (estimated)
Updated on ClinicalTrials.gov	2026-04-24